STM
Journals

STM Journals Special Issues

Be at the Forefront of Research: Submit to Our Special Issues!

Drive Discovery and Advance Your Field

We're excited to announce a selection of cutting-edge Special Issues across various disciplines! These focused collections present a unique opportunity for researchers to contribute to the latest advancements and gain significant exposure within their fields.

Explore Current Research Trends

Browse our dynamic list of Special Issues below. Each topic features a detailed description highlighting its relevance and outlining the scope of research we encourage.

Benefits of Publishing in a Special Issue:

  • Targeted Audience: Reach a community of researchers specifically interested in your area of expertise.
  • Increased Visibility: Gain wider recognition with dedicated promotion of the Special Issue.
  • Fast-Track Review: Benefit from expedited peer-review processes for timely publication.
  • Lasting Impact: Contribute to a focused collection that becomes a valuable resource for future research.

Search For Topics

Topic search
Submit Manuscript
Login/Signup
Join Us
Submit Topic
Propose Conferences

Innovation, Research, and Progress: Read Our Leading Journals Now!
Journals

Connect with Peers and Establish Your Academic Presence: Use Our Profile ID!
APID

Where Ideas Meet Action: Attend Our Innovative Conferences!
STM Conferences

The Key to Your Success: Our Dynamic and Engaging Training Programs!
Training Programs

The Ultimate Platform for Aspiring Authors: Submit Your Manuscript Today!
Manuscript engine






 Special Issue Topics

—
Open Access
Special Issue
Topic

Pathophysiology of Renal erythropoietin- cells

Guest Editor:

        • Abstract Submission Deadline : 30/11/2023

        Manuscript Submission Deadline : 25/12/2023

        [This article belongs to Special Issue Pathophysiology of Renal erythropoietin- cells under section rrjomst, rrjomst in (rrjomst, rrjomst)]

        Special Issue Description

        Chronic kidney illness (CKD) is an issue all over the world with expanding rate and prevalence. Iron deficiency, a well-known complication in CKD, is more visits in patients with lower glomerular filtration rates, particularly those with end-stage renal disease (ESRD) requiring long-term dialysis. Given that renal iron deficiency unfavorably influences the quality of life and is related to destitute results in CKD. Erythropoietin (EPO), a glycoprotein hormone, is the ace controller of erythropoiesis. Later progresses in understanding the physiology and pathophysiology of renal EPO-producing cells (REPCs) give openings to find novel medications by upgrading oxygen detecting instruments and epigenetic modification. Anemia may be a common complication and contributes to expanded horribleness and mortality in constant kidney infection (CKD) patients. Though there has been a noteworthy enhancement in of understanding the fundamental component of erythropoiesis, the treatment of renal frailty is still confined to erythropoietin (EPO)-stimulating operators. The physiology of erythropoiesis, a useful part of EPO, and the fundamental atomic and cellular premise that directs EPO generation. In CKD, plasma EPO level is out of the extent to the degree of anemia. In CKD, pericytes transdifferentiate to myofibroblasts, and hence the capacity of EPO generation diminishes, driving renal iron deficiency. Later exploratory and clinical considerations appear to the promising viability of prolyl hydroxylase inhibitors in renal iron deficiency through expanding EPO generation by stabilizing hypoxia-inducible factor (HIF).

        Editor Keywords

        Chronic kidney illness (CKD), End-stage renal disease (ESRD), Erythropoietin (EPO), Renal EPO-producing cells (REPCs), Epigenetic, Anemia, Hypoxia-inducible factor (HIF)

        Manuscript Submission information

        Manuscripts should be submitted online by registering and logging in to this link. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed.
        Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent on email address:[email protected] for announcement on this website.

        Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

        Participating journals:

        Journal Name

        Research & Reviews : Journal of Medical Science and Technology, Research & Reviews : Journal of Medical Science and Technology

        Abbrivation

        rrjomst, rrjomst

        ISSN

        2319-3417, 2319-3417

        Since

        2012

        APC

        1000  $